IBUY
Asset Logo

BetaShares Online Retail and E-Commerce ETF

πŸ‡¦πŸ‡Ί ASX

πŸ›οΈ CONSUMER

🌏 GLOBAL

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ“™ Holdings

πŸ’΅ Cost

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

+ 6.76%
Annual Growth

3 years average annual growth

πŸ’΅

$ 500
Minimum Order

Due to regulatory requirements

🌏

8
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

IBUY.AX was created on 2022-02-14 by BetaShares. The fund's investment portfolio concentrates primarily on consumer discretionary equity. IBUY.AX aims to track the performance of an Index (before fees and expenses) that provides exposure to a portfolio of the worlds leading online retailers.

🌐 Website

πŸ“ˆ Performance

Price History

+18.48%

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ“™ Top Holdings

Show more

TENCENT HOLDINGS LTD

6.91%
PDD HOLDINGS INC
6.57%

ALIBABA GROUP HOLDING LTD

6.11%

SHOPIFY INC

4.92%

MEITUAN

4.63%

Updated as of 16 July 2024

Industry Exposure
πŸ›οΈ Consumer
39%
πŸ“™ Other
34%
πŸ“ž Communication
12%
🏭 Industrials
10%
🏦 Financials
4%
Country Exposure
πŸ‡ΊπŸ‡Έ United States
47%
πŸ‡¨πŸ‡³ China
32%
πŸ‡§πŸ‡· Brazil
5%
πŸ‡¨πŸ‡¦ Canada
5%
πŸ‡³πŸ‡± Netherlands
3%
πŸ‡ΈπŸ‡¬ Singapore
3%
πŸ‡―πŸ‡΅ Japan
1%
πŸ‡©πŸ‡ͺ Germany
1%
πŸ‡¬πŸ‡§ United Kingdom of Great Britain and Northern Ireland
1%

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

0.67%
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$14.62

πŸ’° Price To Earnings Ratio

28.12

πŸ’° Price To Book Ratio

5.40

πŸ’° Leveraged

No

πŸ’° Inverse

No

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in IBUY

8

πŸ“Š Total Capital Earnings

$22K

πŸ”ƒ Average investment frequency

42 weeks

πŸ’΅ Average investment amount

$2,555

⏰ Last time a customer invested in IBUY

31 days
IBUY investor breakdown
πŸ’΅ Income of investors

More than 200k

10%

150k - 200k

20%

100k - 150k

50k - 100k

50%

Less than 50k

20%
πŸ‘Ά Age of investors

18 - 25

13%

26 - 34

25%

35 - 90

63%
πŸ™‹ Legal gender of investors

Female

50%

Male

50%

Pearlers who invest in IBUY also invest in...

Vanguard Australian Shares Index ETF

VAS

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

3.97%

πŸ“Š Share price

$103.00 AUD

⛳️ DIVERSIFIED

🧱 MATERIALS

πŸ’Έ FINANCIALS

Find Out More

IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

πŸ™Œ Performance (5Yr p.a)

19.70%

πŸ“Š Share price

$59.84 AUD

πŸ“ˆ HIGH PRICE GROWTH

πŸ‡ΊπŸ‡Έ UNITED STATES

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

13.33%

πŸ“Š Share price

$133.02 AUD

πŸ€– TECHNOLOGY

⛳️ DIVERSIFIED

πŸ“ˆ HIGH PRICE GROWTH

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

4.02%

πŸ“Š Share price

$68.10 AUD

⛳️ DIVERSIFIED

🌏 GLOBAL

ETHI.AX was created on 2017-01-05 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes a portfolio of large global stocks identified as Climate Leaders that have also passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.

πŸ™Œ Performance (5Yr p.a)

13.48%

πŸ“Š Share price

$15.50 AUD

⛳️ DIVERSIFIED

πŸ€– TECHNOLOGY

🌏 GLOBAL

πŸ“ˆ HIGH PRICE GROWTH

Want more shares? Try these...

Imagion Biosystems Ltd. engages in the research and development of non-radioactive and safe diagnostic imaging technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-06-22. The firm uses bio-safe magnetic nanoparticles to detect cancer and other diseases. Its principal activity consists of nanotechnology, biotechnology, cancer diagnostics and medical imaging using magnetic resonance. The firm operates through Research and Development segment. The company is advancing clinical development of its MagSense platform technology to revolutionize cancer diagnosis, introducing molecular imaging to Magnetic resonance imaging (MRI). The Company’s lead program has demonstrated its technology embodied in MagSense HER2 Imaging Agent (MSH2IA) is safe and well-tolerated in patients diagnosed with HER2+ breast cancer. Its MagSense pipeline includes prostate cancer, ovarian cancer, pancreatic cancer, and brain cancer programs. Its PrecisionMRX products include Dextran-Coated, mPEG Coated, Oleic Acid Coated and Carboxylic Acid Functionalized.

πŸ™Œ Performance (5Yr p.a)

24.76%

πŸ“Š Share price

$0.05 AUD

πŸ“ˆ HIGH PRICE GROWTH

🩺 HEALTH CARE

iCetana Ltd. engages in the commercialization of video analytics software. The company is headquartered in Perth, Western Australia. The company went IPO on 2019-12-23. The firm provides video analytics technology designed to identify abnormal anomalous actions in real-time for large scale surveillance networks. The company is engaged in the development and sale of artificial intelligence (AI) assisted video surveillance software using technology based on machine learning to provide automatic real-time anomalous event detection. Its technology is implemented across a range of private, public and government industries at approximately 40 sites on four continents. The company has three segments: Asia Pacific (APAC), North America (NA), and Europe, Middle East & Africa (EMEA). APAC segment is engaged in selling, marketing and product development efforts in Australia and the broader Asia Pacific region. NA segment is engaged in selling and marketing efforts in the United States and Canada. EMEA segment is engaged in selling and marketing efforts in Europe, the Middle East and Africa.

πŸ“Š Share price

$0.02 AUD

πŸ€– TECHNOLOGY

πŸ“Š Share price

$11.39 AUD
Compare
Add to watchlist